BAP1 germline mutations are observed in 9–12% of PM patients, although more commonly detected in younger-age patients and in patients with tumors related to BAP1 tumor predisposition syndrome [46]. The gene discussed is BAP1; the disease is BAP1-related tumor predisposition syndrome.